Drawing for AVC-BOOSTER

USPTO serial 79415723

AVC-BOOSTER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, JUSTIN
Law office
TMO LAW OFFICE 111

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AVC-BOOSTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for use in industry, science, and photography, namely, monoclonal antibodies and recombinant proteins used in scientific in-silico, in­vitro, in-vivo, and/or clinical research and development relating to immuno­oncologyACTIVE—
005Pharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; biopharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseasesACTIVE—
041Educational services, namely, arranging and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical development; training services, namely, providing training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical developmentACTIVE—
042Medical and scientific research services; industrial research services in the field of treatment of cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; pharmaceutical and biopharmaceutical research and development services; development, research, laboratory analysis and testing of pharmaceutical and biopharmaceutical drugs and for semi-finished chemicals and chemical products for use in pharmaceuticals; development of test systems in the nature of cell culture models, animal models and companion diagnostics for pharmaceutical and biopharmaceutical products; chemical analysis; computer system analysis and programming, namely, the development of prototypes and collection and processing of medical data for scientific research, development of databases in the medical, pharmaceutical and biopharmaceutical fieldsACTIVE—
044Medical services; medical and pharmaceutical advisory and consultancy services; medical care services.ACTIVE—
045Legal services relating to the exploitation of patents; management and licensing of patents; licensing of intellectual property.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 29, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 29, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 17, 2026MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 17, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 23, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 2, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2025RFRRREFUSAL PROCESSED BY MPU—
Jun 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2025DOCKASSIGNED TO EXAMINER—
Feb 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 30, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance